We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

69 hedge funds and large institutions have $60.1M invested in Ocular Therapeutix in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 73 → 69 (-4)

7.74% less ownership

Funds ownership: 53.62% → 45.88% (-7.7%)

13% less call options, than puts

Call options by funds: $378K | Put options by funds: $434K

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

38% less capital invested

Capital invested by funds: $96.5M → $60.1M (-$36.4M)

Holders
69
Holders Change
-4
Holders Change %
-5.48%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
19
Reduced
23
Closed
15
Calls
$378K
Puts
$434K
Net Calls
-$56K
Net Calls Change
-$188K

Top Buyers

Rank Fund Capital Flow
1
HP
Hikari Power
Japan
+$409K
2
VF
Virtu Financial
New York
+$322K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$214K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$196K
5
Deutsche Bank
Deutsche Bank
Germany
+$153K

Top Sellers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
-$6.63M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.56M
3
CS
Credit Suisse
Switzerland
-$1.07M
4
B
Bailard
California
-$907K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$599K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$190K – – –
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$177K – – –
Charles Schwab
28
Charles Schwab
California
$172K – – –
PPA
29
Parametric Portfolio Associates
Washington
$164K -$68K -13,321 -27%
CS
30
Credit Suisse
Switzerland
$161K -$1.07M -208,844 -85%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$159K -$6.64K -1,300 -4%
Goldman Sachs
32
Goldman Sachs
New York
$156K -$9.15K -1,792 -5%
Neuberger Berman Group
33
Neuberger Berman Group
New York
$151K -$24.5K -4,800 -12%
JP Morgan Chase
34
JP Morgan Chase
New York
$119K -$1.56M -305,873 -92%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$113K -$74.7K -14,628 -36%
MWNA
36
Marshall Wace North America
New York
$112K +$128K +25,133 New
Millennium Management
37
Millennium Management
New York
$99K +$46.8K +9,156 +70%
Squarepoint
38
Squarepoint
New York
$99K +$114K +22,243 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$95K -$43.5K -8,513 -29%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$83K – – –
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$80K – – –
AIG
42
American International Group
New York
$68K +$358 +70 +0.5%
Citigroup
43
Citigroup
New York
$57K +$32.8K +6,425 +99%
Citadel Advisors
44
Citadel Advisors
Florida
$52K +$59.2K +11,589 New
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$50K – – –
VOYA Investment Management
46
VOYA Investment Management
Georgia
$49K – – –
TSS
47
Two Sigma Securities
New York
$49K +$56K +10,970 New
Macquarie Group
48
Macquarie Group
Australia
$31K +$35.2K +6,900 New
TRCT
49
Tower Research Capital (TRC)
New York
$30K +$7.38K +1,445 +27%
Legal & General Group
50
Legal & General Group
United Kingdom
$27K – – –
1
2
3 4

OCUL Hedge Fund Activity: Q4 2017 in Review

69 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q4 2017, worth a combined $60.1M — down 38% from $96.5M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of OCUL and 11 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 19 added.

The largest buyer was Hikari Power, opening a new position worth an estimated $409K. The largest seller was Columbus Circle Investors, exiting entirely with an estimated $6.63M sold.

  • 69 institutional investors held Ocular Therapeutix (OCUL) as of Q4 2017, down from 73 in Q3 2017.
  • Funds reported $60.1M of Ocular Therapeutix stock for Q4 2017, down 38% quarter-over-quarter.
  • 11 funds opened new Ocular Therapeutix positions in Q4 2017 and 15 closed out, a net change of -4 holders.
  • The largest Ocular Therapeutix buyer in Q4 2017 was Hikari Power, an estimated $409K added.
  • The largest Ocular Therapeutix seller in Q4 2017 was Columbus Circle Investors, an estimated $6.63M sold.

Based on aggregated 13F filings for Q4 2017.